Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement
      Biotech

      Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement

      July 22, 2022
      Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022
      Biotech

      Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022

      July 22, 2022
      Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results
      Biotech

      Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results

      July 22, 2022
      BioCryst to Report Second Quarter 2022 Financial Results on August 4
      Biotech

      BioCryst to Report Second Quarter 2022 Financial Results on August 4

      July 22, 2022
      BridgeBio Pharma Announces Founding Affiliation with Bakar Labs, Incubator at UC Berkeley’s Bakar BioEnginuity Hub
      Biotech

      BridgeBio Pharma Announces Founding Affiliation with Bakar Labs, Incubator at UC Berkeley’s Bakar BioEnginuity Hub

      July 22, 2022
      Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
      Biotech

      Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

      July 22, 2022
      Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel
      Biotech

      Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel

      July 22, 2022
      Gritstone to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 4, 2022
      Biotech

      Gritstone to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 4, 2022

      July 22, 2022
      Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
      Biotech

      Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria

      July 22, 2022
      BridgeBio Pharma Announces Academic Collaboration with Baylor College of Medicine to Advance Potential Therapies to Treat Genetic Diseases
      Biotech

      BridgeBio Pharma Announces Academic Collaboration with Baylor College of Medicine to Advance Potential Therapies to Treat Genetic Diseases

      July 22, 2022
      « 1 … 126 127 128 129 130 … 133 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026